The Pharmacy Times® Breast Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancers that occur in the breast, including invasive ductal carcinoma, invasive lobular carcinoma, and less common forms of the disease.
December 5th 2024
The authors suggest that targeted interventions to mitigate financial toxicity should be implemented to better support patients.
Patients With Cancer Facing Higher Rates of Loneliness, Depression During COVID-19 Pandemic
May 12th 2021Loneliness and social isolation have been particularly significant problems for patients with cancer during the COVID-19 pandemic, likely due to isolation and social distancing, according to a study published in Cancer.
Read More
Oncology Pharmacists Play Essential Role in Oncology Care, Managing New Treatments
April 27th 2021Cynthia Lynch, MD, breast cancer program clinical advisor with Cancer Treatment Centers of America, said oncology pharmacists are vital team members who can help ensure optimal treatment and safety for patients with breast cancer.
Watch
Study: Immune Cell That Drives Breast Cancer Could Be Effective Target in Novel Immunotherapies
April 23rd 2021New research findings published in Cell Reports identified a type of immune cells that acts as a major driver of breast cancer growth by preventing the accumulation of a specific protein that induces anti-tumor responses.
Read More
Obesity in Breast Cancer Survivors Linked to Higher Risk of Developing Secondary Cancers
April 19th 2021A new study shows that overweight breast cancer survivors have a statistically significant increased risk of developing second primary cancers, and obesity is strongly associated with an increased risk of various cancer types.
Read More
New Drugs Show Promise in Triple-Negative, HER2-Positive Breast Cancer
April 8th 2021A session at the Community Oncology Alliance virtual 2021 conference noted that clinical trials have found promising new treatments for patients with breast cancer, offering opportunities for future new approvals and indications.
Read More
Personalizing Neoadjuvant and Adjuvant HER2-Targeted Therapy for Breast Cancer
April 6th 2021Understanding breast cancer and which patients may be more vulnerable to long-term treatment effects and which patients may benefit most, can help oncologists design the best personalized neoadjuvant and adjuvant human epidermal growth factor receptor 2 (HER2)-targeted therapy.
Read More
National Study Examines US Mammography Screening Rates During COVID-19 Pandemic
April 5th 2021The study, conducted by investigators from the Breast Cancer Surveillance Coalition (BCSC), had an objective to quantify the impact of the COVID-19 pandemic on both breast cancer screening and diagnostic mammography services in the United States.
Read More
Exposure to Common Preservative During Pregnancy May Increase Breast Cancer Risk
March 23rd 2021Low doses of propylparaben–a chemical preservative found in food, drugs, and cosmetics–can alter pregnancy-related changes in the breast in ways that may lessen the protection against breast cancer normally conveyed by pregnancy hormones.
Read More